| 181 |
URSOLIN |
URSODEOXYCHOLIC ACID 250 MG |
CAPSULE |
PVC-ALU BLISTER |
GALLSTONE DISSOLUTION, PREVENTION OF GALLSTONES, PRIMARY BILLIARY CIRRHOSIS |
NULL |
BERLIN PHARMA LAO CO.,LTD |
BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
THAILAND |
CERTIFICATE RELEASED |
04 I 5727/24 |
2024-04-26 |
2027-04-25 |
View |
| 182 |
UTMOS 30 |
PIOGLITAZONE HYDROCHLORIDE 33.70 MG EQ.TO PIOGLITAZONE 30 MG |
TABLET |
ALU-ALU BLISTER |
TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM, TYPE 2), IS INDICATED FOR MONOTHERAPY AND ALSO IN COMBINATION WITH A SULFONYLUREA, METFORMIN OR INSULIN TOGETHER WITH CONTROL DIET AND EXERCISE |
NULL |
BERLIN PHARMA LAO CO.,LTD |
OSOTH INTER LABORATORIES CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
05 I 3293/09 |
17-JUL-2023 |
16-JUL-2026 |
View |
| 183 |
ADADX |
ADAGRASIB 200 MG |
TABLET |
BOTTLE |
NON-SMALL CELL LUNG CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1128/24 |
24-JUN-2024 |
23-JUN-2027 |
View |
| 184 |
AILEDX |
ALECTINIB 150 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1207/24 |
03-OCT-2024 |
02-OCT-2029 |
View |
| 185 |
AIVODX |
IVOSIDENIB 250 MG |
TABLET |
BOTTLE |
TREATMENT OF CHOLANGIOCARCINOMA |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1054/23 |
03-JAN-2024 |
02-JAN-2027 |
View |
| 186 |
ANAPRIL-S |
ENALAPRIL MALEATE 5 MG |
TABLET |
ALU-ALU STRIP |
TREATMENT OF ALL GRADES OF ESSENTIAL HYPERTENSION AND RENOVASCULAR HYPERTENSION AND CONGESTIVE HEART FAILURE. |
NULL |
BERLIN PHARMA LAO CO.,LTD |
BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
THAILAND |
STEP 1: RECEIVE (RENEW) |
10 I 5299/22 |
11-NOV-2022 |
10-NOV-2025 |
View |
| 187 |
AKADX |
ACALABRUTINIB 100 MG |
CAPSULE |
BOTTLE |
TO TREAT PEOPLE WITH MANTLE CELL LYMPHOMA IN ADULTS |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 0984/23 |
04-JUL-2023 |
03-JUL-2026 |
View |
| 188 |
ANADX |
ANAGRELIDE 0.5 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF THROMBOCYTHEMIA, SECONDARY TO MYELOPROLIFERATIVE NEOPLASMS, TO REDUCE THE ELEVATED PLATELET COUNT AND RISK OF THROMBOSIS AND TO AMELIORATE ASSOCATED SYMPTOMS INCLUDING THROMBO-HEMORRHAGIC EVENTS |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1365/25 |
17-JUN-2025 |
16-JUN-2030 |
View |
| 189 |
APADX |
APELUTAMIDE 60 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION SENSITIVE PROSTATE CANCER, AND NON METASTATIC CASTRATION SENSITIVE PROSTATE CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1209/24 |
03-OCT-2024 |
02-OCT-2029 |
View |
| 190 |
APELIDX |
ALPELISIB 150 MG |
FILM COATED TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1330/25 |
2025-04-21 |
2030-04-20 |
View |
